Journal article icon

Journal article

Vaccination for hepatitis C virus: closing in on an evasive target.

Abstract:

Hepatitis C virus (HCV) infects more than 170 million people globally and is a leading cause of liver cirrhosis, transplantation and hepatocellular carcinoma. Current gold-standard therapy often fails, has significant side effects in many cases and is expensive. No vaccine is currently available. The fact that a significant proportion of infected people spontaneously control HCV infection in the setting of an appropriate immune response suggests that a vaccine for HCV is a realistic goal. A c...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1586/erv.11.55

Authors


Halliday, J More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Experimental Medicine Division, Biomedical Research Centre
Journal:
Expert review of vaccines
Volume:
10
Issue:
5
Pages:
659-672
Publication date:
2011-05-05
DOI:
EISSN:
1744-8395
ISSN:
1476-0584
URN:
uuid:4339430f-499c-4cdf-8031-c149ef324597
Source identifiers:
140587
Local pid:
pubs:140587

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP